Diffusion-Weighted MRI for Quantification of Liver Fibrosis: Preliminary Experience
- 1 October 2007
- journal article
- research article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 189 (4), 799-806
- https://doi.org/10.2214/ajr.07.2086
Abstract
OBJECTIVE. The purpose of this study was to evaluate our preliminary experience using diffusion-weighted MRI for quantification of liver fibrosis. SUBJECTS AND METHODS. Diffusion-weighted MRI with single-shot echo-planar technique at b values of 50, 300, 500, 700, and 1,000 s/mm2 was prospectively performed on 23 patients with chronic hepatitis and on seven healthy volunteers. The apparent diffusion coefficient (ADC) was measured in four locations in the liver. Liver biopsy results (n = 19) were retrospectively reviewed by two hepatopathologists in consensus to determine stage of fibrosis and grade of inflammation. A Mann-Whitney test was used to compare the ADCs between patients classified with respect to having stage 2 or greater versus stage 1 or less fibrosis and stage 3 or greater versus stage or less 2 fibrosis. Receiver operating characteristics analysis was used to assess the performance of ADC in prediction of the presence of stage 2 or greater and stage 3 or greater fibrosis. RESULTS. Using a b value of 500 s/mm2 and all combined b values, we found significantly lower hepatic ADCs in stage 2 or greater versus stage 1 or less fibrosis and stage 3 or greater versus stage 2 or less fibrosis. The mean ADCs (× 10–3 mm2/s) with all b values were 1.47 ± 0.11 (SD) versus 1.65 ± 0.10 for stage 2 or greater versus stage 1 or less fibrosis (p < 0.001) and 1.44 ± 0.07 versus 1.66 ± 0.10 for stage 3 or greater versus stage 2 or less fibrosis (p –3 mm2/s or less). CONCLUSION. Diffusion-weighted MRI can be used for prediction of the presence of moderate and advanced liver fibrosis.Keywords
This publication has 42 references indexed in Scilit:
- Current Treatment and Future Directions in the Management of Chronic Hepatitis B Viral InfectionClinics in Liver Disease, 2005
- Treatment of hepatitis CAmerican Journal Of Medicine, 2005
- Diagnosis, management, and treatment of hepatitis CHepatology, 2004
- Sampling variability of liver fibrosis in chronic hepatitis CHepatology, 2003
- Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infectionThe American Journal of Gastroenterology, 2002
- Cirrhosis: Modified Caudate–Right Lobe RatioRadiology, 2002
- Practices of Liver Biopsy in France: Results of a Prospective Nationwide SurveyHepatology, 2000
- Practice and complications of liver biopsyDigestive Diseases and Sciences, 1993
- Outcome of Patients Hospitalized for Complications after Outpatient Liver BiopsyAnnals of Internal Medicine, 1993
- SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVERThe Lancet, 1986